Amanda Mason is a high-achieving Executive Director and Disease Area Strategy Lead at Amgen, where she spearheads global strategy and early pipeline initiatives for the Inflammation/Immunology franchise. With a robust background in strategy and business development, Amanda leverages her PhD training to drive innovative approaches...
Amanda Mason is a high-achieving Executive Director and Disease Area Strategy Lead at Amgen, where she spearheads global strategy and early pipeline initiatives for the Inflammation/Immunology franchise. With a robust background in strategy and business development, Amanda leverages her PhD training to drive innovative approaches in new product planning within the pharmaceutical industry. Her extensive experience spans multiple therapeutic areas, including immunology/inflammation, cardiovascular/metabolic, respiratory, neurosciences, and infectious diseases, allowing her to bring a comprehensive perspective to her role.
At Amgen, Amanda is the global marketing lead for over six early-stage inflammation programs, guiding them from preclinical phases through to Phase 2 trials. She excels in new product planning, where she is responsible for creating target product profiles, conducting market forecasts, and developing compelling business cases that align with Amgen’s strategic objectives. Her leadership in strategic workstreams encompasses therapeutic area strategies, disease strategies, and life cycle strategies, ensuring that each program is positioned for success in a competitive landscape.
Amanda's role as the product team lead for a preclinical stage small molecule further underscores her expertise in molecular biology and cell biology, as she navigates the complexities of drug development. Her skills in strategic planning, consulting, and project management are complemented by her proficiency in data analysis and scientific writing, enabling her to communicate complex scientific concepts effectively to diverse stakeholders. With a passion for advancing healthcare solutions, Amanda Mason is at the forefront of transforming innovative ideas into impactful therapies that address unmet medical needs.
